Ravi Vij, in Discussion with Dr. Prithviraj Bose MD on Choosing SecondLine Therapy for Myelofibrosis

Ravi Vij, in Discussion with Dr. Prithviraj Bose MD, Professor, Department of Leukemia, MD Anderson Cancer Center on: Choosing Second Line Therapy on Myelofibrosis